trending Market Intelligence /marketintelligence/en/news-insights/trending/q7DQFbIgc_ZFARHQYOri5A2 content esgSubNav
In This List

Rui Kang Pharmaceutical director resigns

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Rui Kang Pharmaceutical director resigns

Rui Kang Pharmaceutical Group Investments Ltd. said Gao Yongping resigned as a nonexecutive director of the company.

Gao resigned due to business commitments elsewhere.